You are here: Industry Insights > Bharat Biotech

News List

SEC meets to discuss EUA applications from Pfizer, SII and Bharat Biotech expresspharma
December 31, 2020
The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) met on December 30, 2020, in the afternoon to consider the Emergency Use Authorisation (EUA) requests of Pfizer, Serum Institute of India (SII) and ...
Vice President Venkaiah Naidu meets Bharat Biotech CMD, discusses status of Covaxin expresspharma
December 28, 2020
Naidu stressed the importance of PPPs in coming out with indigenous world-class products.
Phase I clinical trial outcome shows Covaxin generates antibody, T-cell memory response expresspharma
December 24, 2020
Bharat Biotech’s COVID-19 vaccine Covaxin has shown positive long term antibody and T cell memory response in Phase I clinical trial.
Ocugen and Bharat Biotech to Co-develop COVAXIN for US market expresspharma
December 23, 2020
Companies will co-develop inactivated vaccine candidate, COVAXIN™, to prevent COVID-19 infection in the U.
COVAXIN is well tolerated with no serious adverse events in Phase I trials expresspharma
December 18, 2020
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants across 11 hospitals.
Bharat Biotech to begin trial of intranasal Covid-19 vaccine pharmaceutical-technology
December 10, 2020
Indian firm Bharat Biotech will be commencing Phase I trials of its intranasal Covid-19 vaccine candidate next month.
Team of 70 Ambassadors and High Commissioners visit Bharat Biotech, discuss COVAXIN expresspharma
December 10, 2020
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results.
Bharat Biotech seeks EUA for Covaxin expresspharma
December 08, 2020
No date has been fixed as on when the SEC will meet for assessing and evaluating the applications, as per sources.
Modi visits key vaccine facilities as COVID-19 case load surges expresspharma
November 30, 2020
The companies are testing homegrown vaccine options, as well as working on trials of vaccines being developed overseas.
Homegrown COVID-19 vaccine final trials may conclude within two months: India expresspharma
November 24, 2020
ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page